Centocor's Simponi May Cause Fatal Infections: FDA

Law360, New York (May 29, 2009, 12:00 AM EDT) -- Centocor Ortho Biotech Inc.'s new rheumatoid arthritis drug Simponi can cause severe and potentially fatal fungal infections, according to the U.S. Food and Drug Administration, marking the latest medication in a class of drugs known as tumor necrosis factor alpha blockers to come under scrutiny in recent months.

The FDA posted the warning on its Web site Wednesday along with a "Dear Healthcare Professional" letter that has been issued by Horsham, Pa.-based Centocor in order to warn doctors of the risk of serious fungal infections associated...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.